Logo image of 1ELX.MI

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1ELX - US5184391044 - Common Stock

76.2 EUR
+2.6 (+3.53%)
Last: 11/20/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to 1ELX. 1ELX was compared to 15 industry peers in the Personal Care Products industry. 1ELX may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, 1ELX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

1ELX had positive earnings in the past year.
In the past year 1ELX had a positive cash flow from operations.
Of the past 5 years 1ELX 4 years were profitable.
Each year in the past 5 years 1ELX had a positive operating cash flow.
1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCF1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

1.2 Ratios

1ELX's Return On Assets of -4.81% is on the low side compared to the rest of the industry. 1ELX is outperformed by 93.33% of its industry peers.
1ELX has a worse Return On Equity (-23.91%) than 93.33% of its industry peers.
1ELX has a Return On Invested Capital of 4.69%. This is amonst the worse of the industry: 1ELX underperforms 80.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1ELX is significantly below the industry average of 11.66%.
Industry RankSector Rank
ROA -4.81%
ROE -23.91%
ROIC 4.69%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
1ELX.MI Yearly ROA, ROE, ROIC1ELX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

1ELX has a Operating Margin of 8.72%. This is in the lower half of the industry: 1ELX underperforms 60.00% of its industry peers.
In the last couple of years the Operating Margin of 1ELX has declined.
1ELX has a better Gross Margin (74.18%) than 93.33% of its industry peers.
1ELX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.72%
PM (TTM) N/A
GM 74.18%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
1ELX.MI Yearly Profit, Operating, Gross Margins1ELX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1ELX is destroying value.
The number of shares outstanding for 1ELX has been increased compared to 1 year ago.
Compared to 5 years ago, 1ELX has less shares outstanding
1ELX has a worse debt/assets ratio than last year.
1ELX.MI Yearly Shares Outstanding1ELX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ELX.MI Yearly Total Debt VS Total Assets1ELX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

1ELX has an Altman-Z score of 3.14. This indicates that 1ELX is financially healthy and has little risk of bankruptcy at the moment.
1ELX has a Altman-Z score (3.14) which is in line with its industry peers.
The Debt to FCF ratio of 1ELX is 7.01, which is on the high side as it means it would take 1ELX, 7.01 years of fcf income to pay off all of its debts.
1ELX's Debt to FCF ratio of 7.01 is on the low side compared to the rest of the industry. 1ELX is outperformed by 60.00% of its industry peers.
A Debt/Equity ratio of 1.88 is on the high side and indicates that 1ELX has dependencies on debt financing.
1ELX has a worse Debt to Equity ratio (1.88) than 86.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.88
Debt/FCF 7.01
Altman-Z 3.14
ROIC/WACC0.64
WACC7.34%
1ELX.MI Yearly LT Debt VS Equity VS FCF1ELX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

1ELX has a Current Ratio of 1.32. This is a normal value and indicates that 1ELX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1ELX (1.32) is comparable to the rest of the industry.
A Quick Ratio of 0.92 indicates that 1ELX may have some problems paying its short term obligations.
The Quick ratio of 1ELX (0.92) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.92
1ELX.MI Yearly Current Assets VS Current Liabilites1ELX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

4

3. Growth

3.1 Past

1ELX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.12%.
The earnings per share for 1ELX have been decreasing by -18.22% on average. This is quite bad
1ELX shows a decrease in Revenue. In the last year, the revenue decreased by -6.53%.
The Revenue has been growing slightly by 0.04% on average over the past years.
EPS 1Y (TTM)-36.12%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%128.57%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%3.57%

3.2 Future

The Earnings Per Share is expected to grow by 28.75% on average over the next years. This is a very strong growth
1ELX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.86% yearly.
EPS Next Y46.73%
EPS Next 2Y42.33%
EPS Next 3Y35.62%
EPS Next 5Y28.75%
Revenue Next Year3.87%
Revenue Next 2Y4.03%
Revenue Next 3Y4.21%
Revenue Next 5Y3.86%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ELX.MI Yearly Revenue VS Estimates1ELX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
1ELX.MI Yearly EPS VS Estimates1ELX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 52.55, which means the current valuation is very expensive for 1ELX.
Based on the Price/Earnings ratio, 1ELX is valued expensively inside the industry as 80.00% of the companies are valued cheaper.
When comparing the Price/Earnings ratio of 1ELX to the average of the S&P500 Index (25.98), we can say 1ELX is valued expensively.
1ELX is valuated quite expensively with a Price/Forward Earnings ratio of 28.96.
Based on the Price/Forward Earnings ratio, 1ELX is valued expensively inside the industry as 86.67% of the companies are valued cheaper.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.79, 1ELX is valued at the same level.
Industry RankSector Rank
PE 52.55
Fwd PE 28.96
1ELX.MI Price Earnings VS Forward Price Earnings1ELX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

80.00% of the companies in the same industry are cheaper than 1ELX, based on the Enterprise Value to EBITDA ratio.
1ELX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. 1ELX is more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.35
EV/EBITDA 17.69
1ELX.MI Per share data1ELX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

1ELX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as 1ELX's earnings are expected to grow with 35.62% in the coming years.
PEG (NY)1.12
PEG (5Y)N/A
EPS Next 2Y42.33%
EPS Next 3Y35.62%

2

5. Dividend

5.1 Amount

1ELX has a Yearly Dividend Yield of 1.56%.
The stock price of 1ELX dropped by -28.45% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.02, 1ELX is paying slightly less dividend.
Compared to the average S&P500 Dividend Yield of 2.41, 1ELX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.56%

5.2 History

The dividend of 1ELX has a limited annual growth rate of 4.31%.
Dividend Growth(5Y)4.31%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of 1ELX are negative and hence is the payout ratio. 1ELX will probably not be able to sustain this dividend level.
1ELX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-54.3%
EPS Next 2Y42.33%
EPS Next 3Y35.62%
1ELX.MI Yearly Income VS Free CF VS Dividend1ELX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

ESTEE LAUDER COMPANIES-CL A

BIT:1ELX (11/20/2025, 7:00:00 PM)

76.2

+2.6 (+3.53%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-05 2026-02-05/bmo
Inst Owners95.71%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap27.46B
Revenue(TTM)14.44B
Net Income(TTM)-930.00M
Analysts70.56
Price Target81.05 (6.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.56%
Yearly Dividend1.48
Dividend Growth(5Y)4.31%
DP-54.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.2%
Min EPS beat(2)0.44%
Max EPS beat(2)75.96%
EPS beat(4)4
Avg EPS beat(4)65.82%
Min EPS beat(4)0.44%
Max EPS beat(4)99.01%
EPS beat(8)8
Avg EPS beat(8)73.78%
EPS beat(12)11
Avg EPS beat(12)86.84%
EPS beat(16)15
Avg EPS beat(16)68.13%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-0.06%
Revenue beat(4)0
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)-0.06%
Revenue beat(8)0
Avg Revenue beat(8)-1.81%
Revenue beat(12)1
Avg Revenue beat(12)-1.68%
Revenue beat(16)2
Avg Revenue beat(16)-1.82%
PT rev (1m)7.39%
PT rev (3m)17.83%
EPS NQ rev (1m)2.25%
EPS NQ rev (3m)-1.45%
EPS NY rev (1m)3.57%
EPS NY rev (3m)-3.69%
Revenue NQ rev (1m)2.05%
Revenue NQ rev (3m)4.31%
Revenue NY rev (1m)0.79%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 52.55
Fwd PE 28.96
P/S 2.2
P/FCF 30.35
P/OCF 19.8
P/B 8.15
P/tB N/A
EV/EBITDA 17.69
EPS(TTM)1.45
EY1.9%
EPS(NY)2.63
Fwd EY3.45%
FCF(TTM)2.51
FCFY3.29%
OCF(TTM)3.85
OCFY5.05%
SpS34.7
BVpS9.35
TBVpS-4.65
PEG (NY)1.12
PEG (5Y)N/A
Graham Number17.46
Profitability
Industry RankSector Rank
ROA -4.81%
ROE -23.91%
ROCE 8.84%
ROIC 4.69%
ROICexc 5.55%
ROICexgc 10.76%
OM 8.72%
PM (TTM) N/A
GM 74.18%
FCFM 7.24%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
ROICexc(3y)6.37%
ROICexc(5y)9.94%
ROICexgc(3y)15.14%
ROICexgc(5y)22.74%
ROCE(3y)9.4%
ROCE(5y)13.97%
ROICexgc growth 3Y-33.25%
ROICexgc growth 5Y-18.06%
ROICexc growth 3Y-32.16%
ROICexc growth 5Y-18.64%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.88
Debt/FCF 7.01
Debt/EBITDA 3.52
Cap/Depr 67.84%
Cap/Sales 3.86%
Interest Coverage 3.58
Cash Conversion 76.98%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.92
Altman-Z 3.14
F-Score5
WACC7.34%
ROIC/WACC0.64
Cap/Depr(3y)208.69%
Cap/Depr(5y)173.4%
Cap/Sales(3y)10.24%
Cap/Sales(5y)8.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.12%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%128.57%
EPS Next Y46.73%
EPS Next 2Y42.33%
EPS Next 3Y35.62%
EPS Next 5Y28.75%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%3.57%
Revenue Next Year3.87%
Revenue Next 2Y4.03%
Revenue Next 3Y4.21%
Revenue Next 5Y3.86%
EBIT growth 1Y-21.3%
EBIT growth 3Y-31.36%
EBIT growth 5Y-11.51%
EBIT Next Year102.81%
EBIT Next 3Y38.28%
EBIT Next 5Y27.48%
FCF growth 1Y171.62%
FCF growth 3Y-30.55%
FCF growth 5Y-16.56%
OCF growth 1Y-18.8%
OCF growth 3Y-25.21%
OCF growth 5Y-11.02%

ESTEE LAUDER COMPANIES-CL A / 1ELX.MI FAQ

What is the ChartMill fundamental rating of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1ELX.MI.


What is the valuation status of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to ESTEE LAUDER COMPANIES-CL A (1ELX.MI). This can be considered as Overvalued.


Can you provide the profitability details for ESTEE LAUDER COMPANIES-CL A?

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for 1ELX stock?

The Price/Earnings (PE) ratio for ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is 52.55 and the Price/Book (PB) ratio is 8.15.


Can you provide the expected EPS growth for 1ELX stock?

The Earnings per Share (EPS) of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is expected to grow by 46.73% in the next year.